David E. Szymkowski

4.5k total citations
66 papers, 3.5k citations indexed

About

David E. Szymkowski is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David E. Szymkowski has authored 66 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 20 papers in Molecular Biology and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David E. Szymkowski's work include Monoclonal and Polyclonal Antibodies Research (20 papers), T-cell and B-cell Immunology (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). David E. Szymkowski is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), T-cell and B-cell Immunology (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). David E. Szymkowski collaborates with scholars based in United States, United Kingdom and Denmark. David E. Szymkowski's co-authors include Richard D. Wood, Malú G. Tansey, Seung Y. Chu, Maureen Biggerstaff, John R. Bethea, John R. Desjarlais, Roberta Brambilla, Young S. Kim, James R. Gum and Suzanne Crawley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David E. Szymkowski

64 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Szymkowski United States 33 1.5k 1.0k 579 518 509 66 3.5k
Judith M. Greer Australia 34 874 0.6× 1.8k 1.8× 446 0.8× 318 0.6× 576 1.1× 86 3.7k
Spiros Georgopoulos Greece 18 1.1k 0.8× 1.3k 1.3× 345 0.6× 316 0.6× 648 1.3× 23 3.5k
H. Daniel Perez United States 35 1.1k 0.8× 1.5k 1.4× 251 0.4× 211 0.4× 915 1.8× 87 3.5k
Yoshiyuki Ohsugi Japan 31 1.1k 0.8× 1.3k 1.2× 263 0.5× 386 0.7× 1.1k 2.2× 84 4.0k
Stefan Brocke United States 36 1.2k 0.8× 2.9k 2.8× 465 0.8× 545 1.1× 1.2k 2.4× 76 5.2k
Anthony Slavin United States 28 986 0.7× 1.9k 1.8× 395 0.7× 210 0.4× 617 1.2× 53 3.6k
Mirko H. H. Schmidt Germany 36 2.5k 1.7× 572 0.6× 589 1.0× 262 0.5× 647 1.3× 73 4.5k
Gijs Kooij Netherlands 36 1.2k 0.8× 795 0.8× 1.2k 2.0× 120 0.2× 463 0.9× 70 3.5k
Shohreh Issazadeh‐Navikas Denmark 32 941 0.6× 1.9k 1.8× 833 1.4× 118 0.2× 726 1.4× 76 3.9k
Sigrid R. Ruuls Netherlands 20 489 0.3× 1.3k 1.3× 852 1.5× 204 0.4× 361 0.7× 25 2.5k

Countries citing papers authored by David E. Szymkowski

Since Specialization
Citations

This map shows the geographic impact of David E. Szymkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Szymkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Szymkowski more than expected).

Fields of papers citing papers by David E. Szymkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Szymkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Szymkowski. The network helps show where David E. Szymkowski may publish in the future.

Co-authorship network of co-authors of David E. Szymkowski

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Szymkowski. A scholar is included among the top collaborators of David E. Szymkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Szymkowski. David E. Szymkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, Sara A., et al.. (2025). Peripherally administered TNF inhibitor is not protective against α-synuclein-induced dopaminergic neuronal death in rats. Neurobiology of Disease. 206. 106803–106803. 1 indexed citations
2.
Moore, Gregory L., Juan E. Diaz, Christine Bonzon, et al.. (2024). A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti–PD-1 and CD3 T-cell Engager Immunotherapies. Molecular Cancer Therapeutics. 24(3). 331–344. 11 indexed citations
3.
Bhat, Menakshi, Qian Wu, Erik Pong, et al.. (2021). Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis. The Journal of Immunology. 206(6). 1284–1296. 6 indexed citations
4.
Chu, Seung Y., Erik Pong, Christine Bonzon, et al.. (2020). Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice. SHILAP Revista de lepidopterología. 4. 100075–100075. 17 indexed citations
5.
Lis, Krzysztof, et al.. (2017). Inhibition of TNF reduces mechanical orofacial hyperalgesia induced by Complete Freund’s Adjuvant by a TRPV1-dependent mechanism in mice. Pharmacological Reports. 69(6). 1380–1385. 12 indexed citations
6.
Καραμίτα, Μαρία, Christopher J. Barnum, Wiebke Möbius, et al.. (2017). Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia. JCI Insight. 2(8). 72 indexed citations
7.
Vanwalleghem, Gilles, Yannick Morias, Alain Beschin, David E. Szymkowski, & Étienne Pays. (2017). Trypanosoma brucei growth control by TNF in mammalian host is independent of the soluble form of the cytokine. Scientific Reports. 7(1). 6165–6165. 7 indexed citations
8.
Sondermann, Peter & David E. Szymkowski. (2016). Harnessing Fc receptor biology in the design of therapeutic antibodies. Current Opinion in Immunology. 40. 78–87. 60 indexed citations
9.
Clausen, Bettina Hjelm, Matilda Degn, Nellie Anne Martin, et al.. (2014). Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia. Journal of Neuroinflammation. 11(1). 203–203. 4 indexed citations
10.
Bernett, Matthew J., Seung Y. Chu, Irene Leung, et al.. (2013). Immune suppression in cynomolgus monkeys by XPro9523. mAbs. 5(3). 384–396. 22 indexed citations
11.
Maillet, Isabelle, Silvia Schnyder‐Candrian, Isabelle Couillin, et al.. (2011). Allergic Lung Inflammation Is Mediated by Soluble Tumor Necrosis Factor (TNF) and Attenuated by Dominant-Negative TNF Biologics. American Journal of Respiratory Cell and Molecular Biology. 45(4). 731–739. 22 indexed citations
12.
Tansey, Malú G. & David E. Szymkowski. (2009). The TNF superfamily in 2009: new pathways, new indications, and new drugs. Drug Discovery Today. 14(23-24). 1082–1088. 70 indexed citations
13.
Chu, Seung Y., Igor Voštiar, Sher Karki, et al.. (2008). Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies. Molecular Immunology. 45(15). 3926–3933. 119 indexed citations
14.
Zalevsky, Jonathan, Thomas Sécher, Sergei A. Ezhevsky, et al.. (2007). Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to Infection. The Journal of Immunology. 179(3). 1872–1883. 128 indexed citations
15.
McCoy, Melissa K., Terina N. Martinez, Kelly A. Ruhn, et al.. (2006). Blocking Soluble Tumor Necrosis Factor Signaling with Dominant-Negative Tumor Necrosis Factor Inhibitor Attenuates Loss of Dopaminergic Neurons in Models of Parkinson's Disease. Journal of Neuroscience. 26(37). 9365–9375. 301 indexed citations
16.
Oikonomou, Nikos, Vaggelis Harokopos, Jonathan Zalevsky, et al.. (2006). Soluble TNF Mediates the Transition from Pulmonary Inflammation to Fibrosis. PLoS ONE. 1(1). e108–e108. 115 indexed citations
17.
Szymkowski, David E.. (2003). Chemical genomics versus orthodox drug development. Drug Discovery Today. 8(4). 157–159. 8 indexed citations
18.
Lewis, E. J., Sudhir Agrawal, Scott Cuthill, et al.. (2000). Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus. Antiviral Research. 48(3). 187–196. 20 indexed citations
19.
Szymkowski, David E., M. A. HAJIBAGHERI, & Richard D. Wood. (1993). Electron Microscopy of DNA Excision Repair Patches Produced by Human Cell Extracts. Journal of Molecular Biology. 231(2). 251–260. 12 indexed citations
20.
Szymkowski, David E., et al.. (1989). ADictyostelium discoideumcDNA coding for a protein with homology to the rat ribosomal protein L7. Nucleic Acids Research. 17(13). 5393–5393. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith M. Greer Breakdown of academic impact, for papers by Spiros Georgopoulos Breakdown of academic impact, for papers by H. Daniel Perez Breakdown of academic impact, for papers by Yoshiyuki Ohsugi Breakdown of academic impact, for papers by Stefan Brocke Breakdown of academic impact, for papers by Anthony Slavin Breakdown of academic impact, for papers by Mirko H. H. Schmidt Breakdown of academic impact, for papers by Gijs Kooij Breakdown of academic impact, for papers by Shohreh Issazadeh‐Navikas Breakdown of academic impact, for papers by Sigrid R. Ruuls
Rankless by CCL
2026